
News Releases
Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
LEARN MORE
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
CONCENTRATES
Fresenius Renal Technologies is a leading supplier of hemodialysis concentrates. For over 20 years, we have offered a complete range of acid concentrates designed for customers and patients. Access the latest innovations in dialysate, including citric-based acid concentrates.
1. Kossmann, R., et al (2009). Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study. Clinical Journal of American Society of Nephrology, 4: 1459-1464
2. Ahmad S, Callan R, Cole JJ, Blagg CR. Dialysate made from dry chemicals using citric acid increases dialysis dose. Am J Kidney Dis. 35(3):493-499,2000.
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling.
© 2011-2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, 2008K@home, GranuFlo, NaturaLyte and bibag are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies, Inc. in the United States and is used under license from Advanced Renal Technologies, Inc. All other trademarks are the property of their respective owners. P/N 101345-01 Rev C 07/2019